ReviewArchives of toxicology2025
Protective effects of flavonoids against silver nanoparticles-induced toxicity.
Review in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Plant-Derived Polyphenols in Cancer Therapy: Bridging Molecular Mechanisms and Bioavailability Toward Clinical Translation.Pharmaceutics · 2026Review
- Quercetin mitigates size-dependent oxidative and metabolic toxicity of citrate-coated silver nanoparticles in human erythrocytes.Archives of toxicology · 2026Article
- Transcriptomic and metabolomic analysis reveals key genes and metabolites in common vetch (Vicia sativa L.) response to drought stress.BMC plant biology · 2026Article
- Silver Nanoparticles as Anticancer Agents: Mechanisms Insight, Current Studies, and Limitations.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Polyphenol-functionalized silver nanoparticles promote differential remineralization and reinforcement of demineralized dentin.Journal of applied oral science : revista FOB · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silver nanoparticles (AgNP) are becoming increasingly prevalent in daily life due to their unique properties, which have expanded their application across multiple sectors. This widespread use has led to a marked rise in human exposure to AgNP, raising concerns about their safety and potential health impacts. Studies have demonstrated that AgNP can induce harmful effects, including oxidative stress and pro-inflammatory responses, underscoring the need to identify protective agents to mitigate health risks. Flavonoids, known for their anti-inflammatory and antioxidant properties, hold significant promise as effective agents in mitigating the toxic effects of AgNP. This review examines the current literature on the protective effects of flavonoids against AgNP toxicity. It highlights the underlying mechanisms by which flavonoids exert protective actions, with a focus on relevant pathways and molecular interactions. The results of in vitro and in vivo studies demonstrated that flavonoids exert protective effects against AgNP-induced damages through their antioxidant and anti-inflammatory activity. This analysis underscores the flavonoids potential as a promising strategy to reduce the negative impacts of AgNP, supporting safer and more sustainable applications of nanotechnology across diverse fields.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.